The Effectiveness of a Herbal Supplement in Osteoarthritis.

Sponsor
Middlesex University
Study ID
NCT07324746
Status
Recruiting
Apply to this trial

Conditions

  • Osteoarthritis
  • Osteoarthritis (OA)
  • Osteoarthritis (OA) of the Hip
  • Osteoarthritis (OA) of the Knee

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Active treatment — DIETARY_SUPPLEMENT
    A dietary supplement containing standardised herbal extracts of Boswellia serrata (525 mg), Curcuma longa (150 mg), Vitis vinifera (75 mg). Four times a day.
  • Placebo — OTHER
    A placebo containing no standardised herbal extracts or other active ingredients. Four times a day.

Study Details

This study aims to evaluate the effectiveness and safety of a combined herbal supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera in adults with clinically diagnosed knee or hip osteoarthritis. The primary objective is to determine whether the supplement improves osteoarthritis-related symptoms. The supplement will be compared with a placebo. Participants will: * take the supplement and placebo for 4 weeks each, one at a time; * complete validated questionnaires (6 times online) * perform three performance-based physical tests (6 times online) * provide a urine sample

Key Dates

First listed
Jan 7, 2026
Start date
Dec 5, 2025
Status verified
Jun 2025
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER

Arms

  • Experimental: Active Treatment
    Dietary supplement containing standardised herbal extracts of Boswellia Serrata (525 mg), Curcuma Longa (150 mg), Vitis vinifera (75 mg)
  • Placebo Comparator: Placebo
    Dietary supplement placebo containing no standardised herbal extracts or other active ingredients.

Primary Outcome Measure

Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) score [ Time Frame: Change from the start of the intervention to Week 4 of supplementation ]

Central Contacts

Find similar trials

Nationwide
Osteoarthritis (other) trialsOrthopedics trialsMusculoskeletal disorders trials

Related Studies